NVS Tests 52-Week High Resistance Near $134
$Novartis AG(NVS)$
Gains +0.65%: Swiss Pharma Giant Tests 52-Week High Resistance at $134
Latest Close Data
NVS closed at $131.01 on December 10th, up +0.65% (+$0.84).
The stock trades just 2.4% below its 52-week high of $134.24, showing strong momentum after bouncing from November lows near $96.06.
Core Market Drivers
Novartis continues to benefit from robust pharmaceutical demand and strong pipeline developments.
The company maintains its position as a defensive healthcare play amid market volatility.
Recent capital flows show mixed institutional sentiment with $4.14M net inflow on December 8th after several days of outflows.
Technical Analysis
Volume of 2.13M shares (1.22x average) supported today's advance.
MACD shows bullish momentum with DIF at 0.96 above DEA at 0.79, generating positive histogram at 0.34.
RSI(12) sits at 53.7, indicating neutral territory with room for upside.
KDJ indicators show K-line at 53.5, suggesting consolidation phase.
Key Price Levels
Primary Support: $123.86 (recent technical floor) Strong Resistance: $131.56 (immediate overhead barrier) Immediate Pivot: $130.17 (yesterday's close acting as new support)
Valuation Perspective
NVS trades at 17.95x TTM P/E ratio with forward P/E at 14.57x, slightly above the historical average of 14.20x.
P/S ratio of 4.50x reflects premium valuation for quality pharmaceutical assets. ROE of 32.62% demonstrates exceptional capital efficiency.
Analyst Targets
10 analysts cover NVS with average target price of $122.47 (6.5% downside).
Rating distribution: 1 Strong Buy, 1 Buy, 3 Hold, 3 Underperform. Target range spans $102.36-$147.42, indicating mixed institutional sentiment.
Weekly Outlook
Expect consolidation between $130-$134 as the stock digests recent gains near resistance.
Break above $134.24 could target $140+, while failure to hold $130 support may trigger pullback toward $125 zone.
Risk Disclaimer
This analysis is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Please consult with a qualified financial advisor before making investment decisions.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
